| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |